MedPath

Pulpotomy in Mature Permanent Molars Using Biodentine Versus MTA

Not Applicable
Conditions
Symptomatic Irreversible Pulpitis
Interventions
Procedure: MTA Pulpotomy.
Procedure: Biodentine Pulpotomy
Registration Number
NCT03890835
Lead Sponsor
Cairo University
Brief Summary

The aim of this study is to compare treatment outcomes of pulpotomy in mature permanent teeth using Biodentine versus MTA regarding postoperative pain and success rate.

Detailed Description

* Patients will be clinically and radiographically examined and their eligibility will be assessed.

* Eligible patients will be randomly assigned to one of 2 groups: experimental group (pulpotomy using Biodentine) and the control group (pulpotomy using MTA).

* After adminsrtation of local anesthesia, pulpotomy will be done under rubber dam isolation. The pulp tissue will be removed until the level of the orifices of the canals. After hemostasis is achieved, the capping material will be placed. In the experimental group, the capping material is Biodentine while in the control group, the capping material is MTA

* The cavities will be sealed with resin-modified glass ionomer. Then the teeth will be permanently restored with composite . A post-operative radiograph will be taken.

* The patients will be given a pain diary based on Numerical Rating Scale (NRS) and asked to rate their pain level at the specified times.

* The patients will be recalled after 6 and 12 months post-operatively.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
70
Inclusion Criteria
  • Patients aging between 18-40 years old
  • Patients with symptomatic irreversible pulpitis.
  • Radiographically: Absence or slight widening in periodontal ligament space.
  • Systemically- healthy patients (ASA I or II).
  • Patients who agree to attend for recall appointments and provide written consent.
Exclusion Criteria
  • Severe marginal periodontitis.
  • Necrotic pulp, pulp polyp, tooth tender to percussion, clinical progression into periapical abscess, fistula.
  • Non-restorable teeth, teeth with internal/external root resorption or root canal calcification.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Mineral Trioxide Aggregate (MTA)MTA Pulpotomy.-
BiodentineBiodentine Pulpotomy-
Primary Outcome Measures
NameTimeMethod
Postoperative pain after 6 hours postoperatively6 hours postoperatively

Each patient will be given a pain diary based on Numerical Rating Scale(NRS). NRS is an 11-point scale consisting of numbers from 0 through 10.

0 reading represents "no pain"

1- 3 readings represent "mild pain"

4- 6 readings represent "moderate pain"

7- 10 readings represent "severe pain"

Postoperative pain after 12 hours postoperatively12 hours postoperatively

Each patient will be given a pain diary based on Numerical Rating Scale(NRS). NRS is an 11-point scale consisting of numbers from 0 through 10.

0 reading represents "no pain"

1- 3 readings represent "mild pain"

4- 6 readings represent "moderate pain"

7- 10 readings represent "severe pain"

Postoperative pain after 24 hours postoperatively24 hours postoperatively

Each patient will be given a pain diary based on Numerical Rating Scale(NRS). NRS is an 11-point scale consisting of numbers from 0 through 10.

0 reading represents "no pain"

1- 3 readings represent "mild pain"

4- 6 readings represent "moderate pain"

7- 10 readings represent "severe pain"

Secondary Outcome Measures
NameTimeMethod
Overall (clinical and radiographic) success after 6 months postoperatively.6 months postoperatively

Outcome of overall success will be determined based on clinical and radiographic examination. If there is either clinical or radiographic failure , then the case will be considered as an overall failure.

Overall (clinical and radiographic) success after 12 months postoperatively.12 months postoperatively

Outcome of overall success will be determined based on clinical and radiographic examination. If there is either clinical or radiographic failure , then the case will be considered as an overall failure.

© Copyright 2025. All Rights Reserved by MedPath